TY - JOUR
T1 - Modular expression analysis reveals functional conservation between human langerhans cells and mouse cross-priming dendritic cells
AU - Artyomov, Maxim N.
AU - Munk, Adiel
AU - Gorvel, Laurent
AU - Korenfeld, Daniel
AU - Cella, Marina
AU - Tung, Thomas
AU - Klechevsky, Eynav
N1 - Publisher Copyright:
© 2015 Artyomov et al.
PY - 2015/5/4
Y1 - 2015/5/4
N2 - Characterization of functionally distinct dendritic cell (DC) subsets in mice has fueled interest in whether analogous counterparts exist in humans. Transcriptional modules of coordinately expressed genes were used for defining shared functions between the species. Comparing modules derived from four human skin DC subsets and modules derived from the Immunological Genome Project database for all mouse DC subsets revealed that human Langerhans cells (LCs) and the mouse XCR1+CD8α+CD103+ DCs shared the class I-mediated antigen processing and cross-presentation transcriptional modules that were not seen in mouse LCs. Furthermore, human LCs were enriched in a transcriptional signature specific to the blood cross-presenting CD141/BDCA-3+ DCs, the proposed equivalent to mouse CD8α+ DCs. Consistent with our analysis, LCs were highly adept at inducing primary CTL responses. Thus, our study suggests that the function of LCs may not be conserved between mouse and human and supports human LCs as an especially relevant therapeutic target.
AB - Characterization of functionally distinct dendritic cell (DC) subsets in mice has fueled interest in whether analogous counterparts exist in humans. Transcriptional modules of coordinately expressed genes were used for defining shared functions between the species. Comparing modules derived from four human skin DC subsets and modules derived from the Immunological Genome Project database for all mouse DC subsets revealed that human Langerhans cells (LCs) and the mouse XCR1+CD8α+CD103+ DCs shared the class I-mediated antigen processing and cross-presentation transcriptional modules that were not seen in mouse LCs. Furthermore, human LCs were enriched in a transcriptional signature specific to the blood cross-presenting CD141/BDCA-3+ DCs, the proposed equivalent to mouse CD8α+ DCs. Consistent with our analysis, LCs were highly adept at inducing primary CTL responses. Thus, our study suggests that the function of LCs may not be conserved between mouse and human and supports human LCs as an especially relevant therapeutic target.
UR - http://www.scopus.com/inward/record.url?scp=84935049583&partnerID=8YFLogxK
U2 - 10.1084/jem.20131675
DO - 10.1084/jem.20131675
M3 - Article
C2 - 25918340
AN - SCOPUS:84935049583
SN - 0022-1007
VL - 212
SP - 743
EP - 757
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 5
ER -